TherapyStem

TherapyStem is a South Korean biotechnology company specializing in regenerative medicine, with a primary focus on treating hair loss. The company develops advanced cell therapies using autologous adipose-derived stem cells and stem cell-derived exosomes. Its lead candidate, TS-101, is currently in clinical development for the treatment of androgenetic alopecia, aiming to stimulate hair follicle regeneration and improve hair density. TherapyStem utilizes proprietary technology for the efficient isolation and cultivation of high-purity stem cells to ensure therapeutic efficacy and safety. The company is also exploring the application of its exosome platform for various dermatological and anti-aging indications. Through its innovative approach to cell-based treatments, TherapyStem seeks to address significant unmet needs in the aesthetic and regenerative medicine markets.